GlassScriptPhysician profile
Nader Paksima
NPI 1730140138
$171,131.93
in general payments reported to CMS, 2019-2025
11 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $6,483 · 2021: $23K · 2022: $13K · 2023: $16K · 2024: $19K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Royalty Or License: $45K · Travel and Lodging: $6,049 · Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,000.00 |
| Royalty Or License | $45,330.27 |
| Travel and Lodging | $6,048.97 |
| Food and Beverage | $1,662.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $167,412.06 | 2019-2025 | Variax, Axsos, Augment Injectable |
| Gotham Surgical Solutions & Devices, INC. | $1,241.00 | 2019 | |
| Sonex Health, INC. | $591.36 | 2025 | Sx-One Microknife |
| Encore Medical, LP | $555.00 | 2021 | |
| Arthrex, INC. | $462.45 | 2025 | |
| Acumed LLC | $374.02 | 2019-2025 | Acumed, Inframe Implant, Innate Implant |
| Suvon Surgical LLC | $173.08 | 2025 | |
| Medartis INC. | $141.54 | 2023 | Aptus |
| Skeletal Dynamics INC | $135.00 | 2023 | Geminus, Ijs, Align |
| Bayer Healthcare Pharmaceuticals INC. | $27.63 | 2025 | |
| Endo Pharmaceuticals INC. | $18.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Paksima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.